Toronto - Delayed Quote CAD
Oncolytics Biotech Inc. (ONC.TO)
0.7100
-0.0100
(-1.39%)
At close: May 9 at 3:59:06 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-26,966
-26,966
-28,448
-23,355
-22,433
Investing Cash Flow
-239
-239
20,222
-20,403
-286
Financing Cash Flow
6,636
6,636
31,994
12,205
33,015
End Cash Position
15,942
15,942
34,912
11,666
41,262
Income Tax Paid Supplemental Data
184
184
120
46
35
Capital Expenditure
-239
-239
-8
-55
-286
Issuance of Capital Stock
6,919
6,919
31,620
12,574
32,912
Repayment of Debt
-348
-348
-407
-381
-366
Free Cash Flow
-27,205
-27,205
-28,456
-23,410
-22,719
12/31/2021 - 6/1/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDNA.TO Medicenna Therapeutics Corp.
1.0600
+6.00%
APS.TO Aptose Biosciences Inc.
2.2100
-0.45%
TH.TO Theratechnologies Inc.
3.6100
-5.25%
CYBN.NE Cybin Inc.
9.80
+7.22%
BCT.TO BriaCell Therapeutics Corp.
4.3400
-1.36%
ERNA Ernexa Therapeutics Inc.
0.1996
-0.15%
AURA Aura Biosciences, Inc.
5.23
-9.83%
SKYE Skye Bioscience, Inc.
1.8100
+1.12%
VANI Vivani Medical, Inc.
1.0400
+1.96%
ACTU Actuate Therapeutics, Inc. Common stock
10.35
+4.55%